Elinzanetant for Vasomotor Symptoms from Endocrine Therapy for Breast Cancer
F
Fatima Cardoso
S
Susanne Parke
(Bayer, Berlin)
D
Donal J. Brennan
(University College Dublin Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin)
P
Paula Briggs
(Liverpool Women’s Hospital, Liverpool, United Kingdom)
G
Gilbert Donders
(Department of Clinical Research for Women, Femicare, Tienen, Belgium)
N
Nick Panay
(Queen Charlotte’s and Chelsea Hospital, Imperial College London, London)
N
Nazanin Haseli-Mashhadi
(Bayer, Reading, United Kingdom)
M
Michael Block
(Bayer, Leverkusen, Germany)
C
Cecilia Caetano
(Bayer, Basel, Switzerland)
M
Maja Francuski
(Bayer, Berlin)
C
Claudia Haberland
(Bayer, Berlin)
K
Kaisa Laapas
(Bayer, Espoo, Finland)
C
Christian Seitz
L
Lineke Zuurman
(Bayer, Basel, Switzerland)
Article Details
Journal
New England Journal of Medicine
Volume / Issue
Vol. 393, Issue 8
Published
August 21, 2025
Pages
753-763
ISSN
0028-4793
Publisher
Massachusetts Medical Society
Journal Info
New England Journal of Medicine
Massachusetts Medical Society
ISSN: 0028-4793 Social Sciences
Authors (14)
F
Fatima Cardoso
S
Susanne Parke
Bayer, Berlin
D
Donal J. Brennan
University College Dublin Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin
P
Paula Briggs
Liverpool Women’s Hospital, Liverpool, United Kingdom
G
Gilbert Donders
Department of Clinical Research for Women, Femicare, Tienen, Belgium
N
Nick Panay
Queen Charlotte’s and Chelsea Hospital, Imperial College London, London
N
Nazanin Haseli-Mashhadi
Bayer, Reading, United Kingdom
M
Michael Block
Bayer, Leverkusen, Germany
C
Cecilia Caetano
Bayer, Basel, Switzerland
M
Maja Francuski
Bayer, Berlin
C
Claudia Haberland
Bayer, Berlin
K
Kaisa Laapas
Bayer, Espoo, Finland
C
Christian Seitz
L
Lineke Zuurman
Bayer, Basel, Switzerland
Related Articles from this Journal
Doctor’s Dirty Little Secret — The Cost of Silence
Tara Khan
Aug 2026
10.1056/nejmp2515506
Obstructive Hypertrophic Cardiomyopathy
Julian-Kai Nishizono, Marohito Nakata
Aug 2026
10.1056/nejmicm2603868
T-Cell Engager–Mediated HLA Antibody Depletion before Kidney Transplantation
Martina Schatzl, Katharina A. Mayer et al.
Jul 2026
10.1056/nejmc2603853
Products That Pose Health Risks — Can Litigation Protect Us When Government Fails?
Jerry Avorn
Jul 2026
10.1056/nejmp2604841
Precision Intensification in Metastatic Prostate Cancer
Rana R. McKay
Jul 2026
10.1056/nejme2605582